Somerville, Massachusetts
United States
56
2026-03-26
The entities that hold a legal rights for patent applications filed by inventor Jacques Vincent:
Vincent Jacques from Somerville, US has applied for patents for these inventions. The list has both pending applications and granted patents:
SOLID FORMS OF ENANTIOPURE DEUTERIUM-ENRICHED BUPROPION AND METHODS OF USE THEREOF
#2 | 2025-08-28METHODS OF TREATING NEUROLOGICAL, METABOLIC, AND OTHER DISORDERS USING ENANTIOPURE DEUTERIUM-ENRICHED PIOGLITAZONE
#3 | 2025-07-24MODIFIED FORMS OF AMBROXOL FOR THERAPEUTIC USE
#4 | 2025-01-09MODIFIED FORMS OF AMBROXOL FOR THERAPEUTIC USE
#5 | 2024-12-31Solid forms of enantiopure deuterium-enriched bupropion and methods of use thereof
#6 | 2024-12-19METHODS OF TREATING NEUROLOGICAL AND OTHER DISORDERS USING ENANTIOPURE DEUTERIUM-ENRICHED BUPROPION
#7 | 2023-09-26Methods of synthesizing enantiopure deuterium-enriched pioglitazone
#8 | 2023-07-13COMBINATION THERAPY USING ENANTIOPURE, OXY-SUBSTITUTED, DEUTERIUM-ENRICHED 5-(BENZYL)-5-DEUTERO-THIAZOLIDINE-2,4-DIONES FOR TREATMENT OF MEDICAL DISORDERS
#9 | 2023-03-09CRYSTALLINE FORMS OF DEUTERIUM-ENRICHED PIOGLITAZONE
#10 | 2022-11-175-DEUTERO-THIAZOLIDINE-2,4-DIONE COMPOUNDS AND METHODS OF TREATING MEDICAL DISORDERS USING SAME
#11 | 2022-07-07METHODS OF TREATING NEUROLOGICAL AND OTHER DISORDERS USING ENANTIOPURE DEUTERIUM-ENRICHED BUPROPION
#12 | 2022-07-075-deutero-2,4-thiazolidinedione derivatives and compositions comprising and methods of using the same
#13 | 2022-06-23METHODS OF TREATING NEUROLOGICAL, METABOLIC, AND OTHER DISORDERS USING ENANTIOPURE DEUTERIUM-ENRICHED PIOGLITAZONE
#14 | 2021-12-30Crystalline forms of deuterium-enriched pioglitazone
#15 | 2021-12-16METHODS OF TREATING NEUROLOGICAL AND OTHER DISORDERS USING ENANTIOPURE DEUTERIUM-ENRICHED BUPROPION
#16 | 2021-11-04Deuterium-enriched isoindolinonyl-azepanediones and related compounds and methods of treating medical disorders using same
#17 | 2020-12-17COMBINATION THERAPY USING ENANTIOPURE, OXY-SUBSTITUTED, DEUTERIUM-ENRICHED 5-(BENZYL)-5-DEUTERO-THIAZOLIDINE-2,4-DIONES FOR TREATMENT OF MEDICAL DISORDERS
#18 | 2020-08-135-DEUTERO-THIAZOLIDINE-2,4-DIONE COMPOUNDS AND METHODS OF TREATING MEDICAL DISORDERS USING SAME
#19 | 2020-07-305-DEUTERO-THIAZOLIDINYLDIONE COMPOUNDS AND METHODS OF TREATING MEDICAL DISORDERS USING SAME
#20 | 2020-05-14HISTONE DEACETYLASE INHIBITORS
#21 | 2020-01-025-deutero-2,4-thiazolidinedione derivatives and compositions comprising and methods of using the same
#22 | 2019-12-19HDAC INHIBITORS
#23 | 2019-09-05Methods of treating neurological, metabolic, and other disorders using enantiopure deuterium-enriched pioglitazone
#24 | 2019-08-01Histone deacetylase inhibitors
#25 | 2018-12-27Histone deacetylase inhibitors
#26 | 2018-12-20HDAC inhibitors
#27 | 2018-11-15Histone deacetylase inhibitors
#28 | 2018-07-26Histone deacetylase inhibitors
#29 | 2018-05-175-deutero-2,4-thiazolidinedione derivatives and compositions comprising and methods of using the same
#30 | 2018-05-10METHODS OF TREATING BACTERIAL INFECTIONS AND FUNGAL INFECTIONS USING ENANTIOPURE DEUTERIUM-ENRICHED PIOGLITAZONE
#31 | 2018-05-105-DEUTERO-THIAZOLIDINE-2,4-DIONE COMPOUNDS AND METHODS OF TREATING MEDICAL DISORDERS USING SAME
#32 | 2018-05-03Deuterium-enriched isoindolinonyl-piperidinonyl conjugates and oxoquinazolin-3(4H)-yl-piperidinonyl conjugates and methods of treating medical disorders using same
#33 | 2018-05-035-DEUTERO-THIAZOLIDINYLDIONE COMPOUNDS AND METHODS OF TREATING MEDICAL DISORDERS USING SAME
#34 | 2018-05-03COMBINATION THERAPY USING ENANTIOPURE, OXY-SUBSTITUTED, DEUTERIUM-ENRICHED 5-(BENZYL)-5-DEUTERO-THIAZOLIDINE-2,4-DIONES FOR TREATMENT OF MEDICAL DISORDERS
#35 | 2017-12-28METHODS OF TREATING NEUROLOGICAL AND OTHER DISORDERS USING ENANTIOPURE DEUTERIUM-ENRICHED BUPROPION
#36 | 2017-11-07Deuterium-enriched isoindolinonyl-piperidinonyl conjugates and oxoquinazolin-3(4H)-yl-piperidinonyl conjugates and methods of treating medical disorders using same
#37 | 2017-02-23Histone deacetylase inhibitors
#38 | 2017-02-16Histone deacetylase inhibitors
#39 | 2016-11-17Methods of treating neurological, metabolic, and other disorders using enantiopure deuterium-enriched pioglitazone
#40 | 2016-10-27Methods of treating neurological and other disorders using enantiopure deuterium-enriched bupropion
#41 | 2016-05-12ADENOSINE ANALOGS AND THEIR USE
#42 | 2016-02-04HDAC inhibitors
#43 | 2015-06-11Histone deacetylase inhibitors
#44 | 2014-02-20Histone deacetylase inhibitors
#45 | 2014-02-06Adenosine analogs and their use
#46 | 2013-11-28Histone deacetylase inhibitors
#47 | 2012-05-10Methods for collagen imaging
#48 | 2012-04-12Bicyclic Compounds and Methods of Making and Using Same
#49 | 2011-09-29Adenosine analogs and their use
#50 | 2010-08-05Bicyclic compounds and methods of making and using same
#51 | 2008-03-06METHODS OF MYOCARDIAL IMAGING
#52 | 2008-02-21Methods of collagen imaging
#53 | 2008-02-21METHODS FOR LYMPH SYSTEM IMAGING
#54 | 2007-01-04Hydroxypyridinone derivatives, metal complexes thereof and the use thereof for preparing conjugates with biomolecules
#55 | 2006-12-28Conjugates of hydroxypyridinone derivative metal complexes with biomolecules and their use for MRI diagnosis
#56 | 2006-12-07Chemical exchange saturation transfer contrast agents
549019 ⎘